These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4193305)

  • 1. [Criteria for recovery from diffuse toxic goiter].
    Baranov VG; Nikolaenko NF
    Klin Med (Mosk); 1970 Apr; 48(4):50-3. PubMed ID: 4193305
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thyroid function and the state of the hypothalamus-hypophysis-thyroid in patients with diffuse toxic goiter after treatment].
    Aliakparova ASh
    Sov Med; 1973 Dec; 36(12):45-8. PubMed ID: 4130665
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and morphologic comparisons in toxic goiter].
    Grigor'ev PIa; Samoteĭkin MA; Korolev RV
    Arkh Patol; 1967; 29(6):55-8. PubMed ID: 4178179
    [No Abstract]   [Full Text] [Related]  

  • 4. [Osteocalcin in diffuse toxic goiter].
    Balabolkin MI; Khaiutina TL; Mkrtumian AM
    Ross Med Zh; 1992; (1):13-5. PubMed ID: 1377070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsiveness to thyrotropin releasing hormone and thyroid suppressibility in Graves' disease patients remaining in remission after antithyroid drug therapy.
    Rajatanavin R; Mahatumarat P; Poochanugool L; Kumpolpunth S; Himathongkam T
    J Med Assoc Thai; 1981 Jan; 64(1):11-8. PubMed ID: 6163837
    [No Abstract]   [Full Text] [Related]  

  • 6. [Normalization of the functional regulation of the thyroid as a criterion of the remission of diffuse toxic goiter following antithyroid treatment].
    Khelds AO
    Probl Endokrinol (Mosk); 1986; 32(4):11-4. PubMed ID: 2429297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressibility of thyroid function during treatment with antithyroid drugs in Grave's disease.
    Wils JA; Kloppenborg PW
    J Clin Endocrinol Metab; 1970 Mar; 30(3):406-7. PubMed ID: 4189571
    [No Abstract]   [Full Text] [Related]  

  • 8. [Radioisotopic indices of thyroid gland function in diffuse toxic goiter in the central Tien Shan mountains].
    Israilov AI; Kaliuzhnyĭ IT
    Zdravookhr Kirg; 1977; (2):20-3. PubMed ID: 17970
    [No Abstract]   [Full Text] [Related]  

  • 9. Abnormal liver function test in Graves' disease: a prospective study of comparison between the hyperthyroid state and the euthyroid state.
    Sarinnapakorn V; Noppavetchwich P; Sunthorntepwarakul T; Deerochanawong C; Ngongamrut S
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S11-6. PubMed ID: 21717872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Problems in curing diffuse toxic goiter].
    Potin VV; Khramtsova VIa; Shliakhtina LG
    Sov Med; 1978 Jun; (6):18-21. PubMed ID: 580976
    [No Abstract]   [Full Text] [Related]  

  • 11. [The hypothalamo-hypophyseo-thyroid system in relatives of patients with diffuse toxic goiter].
    Navarro Despaigne D; Speck Garzón P; Alávez Martín E
    Rev Clin Esp; 1985 Apr; 176(6):299-301. PubMed ID: 3839088
    [No Abstract]   [Full Text] [Related]  

  • 12. [Inorganic and organic phases of radioiodine metabolism in the thyroid in Basedow patients treated with synthetic thyroid antagonists].
    Valentini F; Lodeserto A; Reschini E; Vivarelli S; Miedico D
    Folia Endocrinol; 1968 Aug; 21(4):385-95. PubMed ID: 4186148
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
    Bürgi U; Gerber H; Peter HJ
    Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructure of human thyroid. A study of normal thyroid, untreated and treated diffuse toxic goiter.
    Heimann P
    Acta Endocrinol (Copenh); 1966; 53():Suppl 110:1+. PubMed ID: 4162591
    [No Abstract]   [Full Text] [Related]  

  • 15. [Correlation between the protein-bound iodine and butanol-extracted iodine in the blood serum of patients with diffuse toxic goiter during treatment with mercazolyl].
    Okulov VB
    Probl Endokrinol (Mosk); 1969; 15(4):5-8. PubMed ID: 4189655
    [No Abstract]   [Full Text] [Related]  

  • 16. Recovery from pancytopaenia and liver dysfunction after administration of propylthiouracil for Graves' disease.
    Kebapcilar L; Yeşil S; Bayraktar F; Saklamaz A; Demir T; Güngör O; Alacacioglu I; Cömlekçi A
    N Z Med J; 2005 Aug; 118(1220):U1615. PubMed ID: 16132076
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of antithyroid drugs on the thyroid gland blood vessels in Basedow's disease].
    Yamasaki T
    Yonago Acta Med; 1966 Jul; 10(2):69-73. PubMed ID: 4167195
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current therapy of complicated forms of diffuse toxic goiter].
    Starkova NT; Kotova GA
    Ter Arkh; 1980; 52(8):56-9. PubMed ID: 6167001
    [No Abstract]   [Full Text] [Related]  

  • 19. Post-therapeutic thyroid reserve. Thyroid reserve in euthyroid patients after ablative therapy for diffuse toxic goiter.
    Prendergast JJ; Miller JM
    Henry Ford Hosp Med J; 1970; 18(1):3-10. PubMed ID: 5467196
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of lithium carbonate in treating patients with diffuse toxic goiter].
    Balabolkin MI; Petunina NA; Tsaguriia KG
    Klin Med (Mosk); 1990 Oct; 68(10):68-9. PubMed ID: 1706446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.